Medicared For All Logo

Vijay Balasubramanian MD in Fresno, California

Home California Fresno

Vijay Balasubramanian MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 1348 W Herndon Ave in Fresno, California. There is an additional office location, for a total of two, for Vijay Balasubramanian MD that can be viewed further down. They attended Sorry, his university is not listed and graduated in 1993 (around 31 years of experience). They are listed as doing telehealth appointments.


Vijay Purushoth Balasubramanian MD Office Phone and Directions

Vijay Balasubramanian MD
1348 W Herndon Ave
Fresno, California 93711
559-573-7260


Patient Ratings
Please rate your experience with Vijay Balasubramanian MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 559-573-7260


Enter a starting address:


Healthcare Info for Vijay Balasubramanian MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1993
The Primary Medical Specialty for Vijay Balasubramanian MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 6406855386
NPI #: 1548289093
NPI Created On: 07/18/2006
NPI Last Updated Listed as: 08/03/2022
Primary Taxonomy Code: 207R00000X
License Number:
A94876
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Measurement and graphic recording of total and timed exhaled air capacity
  2. Measurement and graphic recording of total and timed exhaled air capacity
  3. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  4. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  5. Test for exercise-induced lung stress
  6. Test for exercise-induced lung stress
  7. Determination of lung volumes using plethysmography
  8. Determination of lung volumes using plethysmography
  9. Measurement of lung diffusing capacity
  10. Measurement of lung diffusing capacity
  11. New patient office or other outpatient visit, typically 45 minutes
  12. Established patient office or other outpatient, visit typically 25 minutes
  13. Established patient office or other outpatient, visit typically 40 minutes
  14. Initial hospital inpatient care, typically 70 minutes per day
  15. Subsequent hospital inpatient care, typically 35 minutes per day
  16. Critical care delivery critically ill or injured patient, first 30-74 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $108

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788371007

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788371003

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788371005

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788371009

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14


Payments Total: $2,083

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 839126695

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PAH

Name of Drug #1: TYVASO

Open Associated Drug #1: 66302-206-01


Payments Total: $122

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839128677

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PAH

Name of Drug #1: TYVASO

Open Associated Drug #1: 66302-206-01


Payments Total: $101

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839128679

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PAH

Name of Drug #1: ORENITRAM

Open Associated Drug #1: 66302-302-01

Drug or Biological: Drug

Product Category #2: PAH

Name Of Drug #2:: TYVASO

Associated Drug #2: 66302-206-01

Drug or Biological #3:: Drug

Product Category #3: PAH

Name of Drug: REMODULIN

Name Of Drug #3: 66302-110-01


Payments Total: $76

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839134831

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PAH

Name of Drug #1: ORENITRAM

Open Associated Drug #1: 66302-302-01

Drug or Biological: Drug

Product Category #2: PAH

Name Of Drug #2:: TYVASO

Associated Drug #2: 66302-206-01


Payments Total: $49

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839134833

Being Disputed:: No

Product Related: No


Payments Total: $53

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839134835

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PAH

Name of Drug #1: REMODULIN

Open Associated Drug #1: 66302-110-01


Additional Office Locations

1. Fresno Community Hospital And Medical Center
2755 Herndon Ave
Clovis, CA 93611
Group Members: 51

Phone: 559-573-7260

Enter a starting address:


Pulmonary Disease Professionals in Fresno

2823 Fresno St
Fresno, CA
Fresno Community Hospital And Medical Center

6733 N Willow Ave
Fresno, CA
University Faculty Associates Inc

1379 E Herndon Ave
Fresno, CA
Saint Agnes Medical Foundation

1221 E Spruce Ave
Fresno, CA
Saint Agnes Medical Foundation

1660 E Herndon Ave
Fresno, CA

1660 E Herndon Ave
Fresno, CA
Arya Medical Group Corp

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry